Chemical Intermediate Baricitinib CAS 1187594-09-7 Baricitinib Powder

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: API
• Certification: GMP, ISO 9001
• Suitable for: All
• State: Solid
• Purity: >99%
• Keyword: Baricitinib
• Sample: Available
• MOQ: Consult
• Mf: C16h17n7o2s
• CAS: 1187594-09-7
• Test Method: HPLC
• Transport Package: Aluminum Foil Bag/Paper Drum
• Specification: 99%
• Trademark: xinlu
• Origin: China
• Production Capacity: 100kg

Product Description

 

Baricitinib (baricitinib) obtained FDA emergency authorization (EUA) to be used in combination with Redecivir to improve patients who require supplemental oxygen, intubation ventilation or extracorporeal membrane oxygenation, children over 2 years of age, or adult hospitalized patients with new coronary pneumonia or Suspected patient. The FDA emergency authorization is based on a clinical trial (ACTT-2) conducted by the National Institute of Allergy and Infectious Diseases (ACTT-2). Compared with radcivir monotherapy, baritinib is combined with radcivir. It can reduce the patient's recovery time during the 29-day improvement period.

 

 

 

Product name	CAS 1187594-09-7 Baricitinib
CAS	1187594-09-7
Purity	99%
Appearance	White fine powder
Shelf life	2 years
Storage	Cool and dry place

1. Baricitinib, sold under the brand name Olumiant among others, is a drug for the treatment of rheumatoid arthritis (RA) in adults whose disease was not well controlled using RA medications called tumor necrosis factor (TNF) antagonists.

1. Baricitinib, an oral inhibitor of JAK kinases 1 and 2, is commonly prescribed in adults for moderate to severe active rheumatoid arthritis (RA). In patients with rheumatoid arthritis who have not previously used biologic DMARDS, brectinib can reduce disease activity.

Related products

Product Name	CAS No.	Product Name	CAS No.
Lufenuron	103055-07-8	Toltrazuril	69004-03-1
Nitenpyram	120738-89-8	Praziquantel/Biltricide	55268-74-1
Fenbendazole	43210-67-9	Tetramisole Hcl	5086-74-8
Levamisole	14769-73-4	Ponazuril	9004-4-2
Diclazuril	101831-37-2	Florfenicol	73231-34-2
Albendazole	54965-21-8	Mebendazole	31431-39-7
Ivermectin	70288-86-7	Enrofloxacin Hcl	112732-17-9
RU 58841	154992-24-2	cb-03-01	19608-29-8
Biotin	58-85-5	Biotinoyl tripeptide-1	299157-54-3
Finasteride	98319-26-7	Dutasteride	164656-23-9

Xi'an Xinlu Biotechnology Co., Ltd. is a high-end brand company focusing on the biomedical industry and integrating R&D, production and sales.  It has an independent R&D center, advanced laboratory equipment and a professional R&D team, a GMP standard production workshop, a complete set of internationally advanced assembly line equipment, a preparation workshop with a cleanliness level of 100,000, as well as sophisticated testing instruments and scientific testing methods, providing solid technical support for the production of high-quality products.  Through long-term R&D, production, and sales practices, it has formed its own unique product line, providing users with products of reliable quality at highly affordable prices.  We strictly control quality, ensure the stability of product quality in all aspects, and win the trust of customers with high quality and high-level development.